• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
  • Issues
    • Current Issue
    • Issue Archives
  • Editor's Update
  • Advertise
  • Reprints
  • Authors
    • Author Instructions
    • Submission Portal
  • Reviewers
  • Contact

Search

Volume 7 - Issue 6 - June 2010

Case Study »

Simvastatin-Induced Vasculitis with Secondary Mesenteric Ischemia and Intestinal Infarction

By: Alissa S. Brotman O’Neill, DO, Jausheng Tzeng, MD, Herbert Dardik, MD


Abstract

We report an unusual presentation of vasculitis associated with simvastatin. A 69-year-old female patient presented with a 1-day history of acute abdominal pain. However, she had recently been placed on a statin and had started to complain of abdominal pain 2 weeks after starting the medication. Initial investigation of her abdominal pain was negative. An exploratory laparotomy revealed necrotic bowel, which was resected. A pathology report noted acute and chronic vasculitis. A computed tomographic angiogram prior to her exploratory laparotomy showed no arterial

Read the full story »

Book Review »

Review of Textbook on Peripheral Vascular Disease

By: Reviewed by Robert S. Dieter, MD, RVT and Aravinda Nanjundappa, MD, RVT



Title: Peripheral Vascular Disease (ISBN-13: 9780763755386, Paperback, 204 pages, © 2011)

Authors: Alvar Alonso, MD, David D. McManus, MD, Daniel Z. Fisher, MD

Publisher: Jones & Bartlett Learning (Sudbury, Massachusetts, www.jblearning.com)



Dr. Alonso is a cardiology fellow at the University of Massachusetts Medical School in Worcester. Dr. McManus is an assistant professor of medicine at the University of Massachusetts Medical School, UMass Memorial Medical Center and, Dr. Fisher is the director of Interventional Cardiology and the Inter

Read the full story »

Interview »

CREST: Further Data Analysis Confirms Wisdom of Appropriate Patient Stratification

By: Vascular Disease Management Speaks with Christopher J. White, MD, a CREST Trial Investigator


What can you tell us about the latest findings from the CREST trial (Carotid Revascularization Endarterectomy vs. Stenting Trial) and the further evaluation of the data?

There is now more “texture” to the data, but the conclusion is still that there are no significant differences between the outcomes with carotid artery stenting (CAS) and carotid endarterectomy CEA). In essence, there were more minor strokes in the CAS group and more myocardial infarctions (MI) in the CEA group. Since there were three endpoints, they essentially evened out. The debates have tended to

Read the full story »

Case Report »

Aneurysm Rupture Following Limb Disconnection of a Zenith Stent Graft

By: Rabih Houbballah, MD, Hicham Kobeiter, MD, Jean-Pierre Becquemin, MD


Abstract

We report the case of a ruptured abdominal aortic aneurysm (AAA) related to a Type III endoleak which occurred 3 years after treatment of the AAA with a Zenith Cook stent graft. This report will also discuss the mechanism of occurrence and means of detection.

An 81-year-old female underwent elective treatment of a 55 mm AAA using a right aorto-uni-iliac Zenith Cook stent graft. During follow-up, a Type II endoleak was detected and was responsible for a 4 mm aneurysm sac diameter increase. At 30 months, the patient experienced a secondary AAA rupture due to a

Read the full story »

Commentary »

Endograft Assessment for EVAR Follow-up

By: Daniel G. Clair, MD



In this issue of Vascular Disease Management, the article “Aneurysm Rupture Following Limb Dissection of a Zenith Stent-Graft” by Houbballah et al points out several important issues regarding placement and long-term follow-up of patients with endovascular grafts used to treat aneurysmal disease. First, it is important to thoroughly understand the “anatomy” of the endovascular graft that you are using. In particular, as it relates to the Cook Zenith graft, it is important to understand the relationships between the overlapping zones of the limb placed in the pr

Read the full story »

  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Tara Fields, Classified Sales Manager
    (800) 237-7285, ext. 259

vdm Blogs

EVAR found superior to open AAA repair for long-term survival in Medicare patients: Another nail in open surgery’s coffin?

Frank J Criado MD FACS FSVM

Aneurysms and Cancer: Which comes first in the endovascular era?

Ross Milner MD FACS

What is the best therapy when we compare current data for revascularization of the SFA?

Lawrence A. Garcia MD

When a Patient Presents with an Ulcer, Take a Careful History

Richard R. Heuser MD FACC FACP FESC FSCAI

Long-term results with bare-metal LifeStent in the SFA: Is this bad news for DES technologies?

Frank J Criado MD FACS FSVM
more »

Vascular Newswire

  • PROMUS Element Stent Demonstrates Excellent Long-Term Safety and Effectiveness in PLATINUM Small Vessel Study
    Mon, 05/21/12 - 9:50am
  • Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe
    Thu, 05/17/12 - 10:22am
  • Abbott's XIENCE PRIME and XIENCE V Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy
    Wed, 05/16/12 - 9:26am
  • Hospital Mortality Rates for Cardiovascular Revascularization Patients Varies Significantly by State
    Tue, 05/15/12 - 9:31am
more »

Clinical Events Calendar

  • International Vein Congress (IVC) 2012
    Thu, 05/31/2012 - Sun, 06/03/2012
    Miami Beach, FL, United States
  • New Cardiovascular Horizons (NCVH)
    Wed, 06/06/2012 - Sat, 06/09/2012
    New Orleans, LA, United States
  • Peripheral Vascular Surgery Society Annual Spring Meeting
    Thu, 06/07/2012 - Sat, 06/09/2012
    National Harbor, MD, United States
more »

Poll

The current focus to decrease the profile size of aortic stent-grafts: :
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2012 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2012 HMP Communications